GYRE THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Gyre Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Gyre Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $4.54M, a 20.4% increase year-over-year.
  • Gyre Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$79M, a 219% decline year-over-year.
  • Gyre Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$85.5M, a 2081% decline from 2022.
  • Gyre Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $4.31M.
  • Gyre Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$87.9M, a 56.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$79M $4.54M +$768K +20.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$79.8M $9.94M +$5.72M +136% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-13
Q4 2023 -$85.5M -$91.9M -$64M -229% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$21.5M -$1.58M +$3.31M +67.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 -$24.8M $3.77M -$47.9M -92.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $23.1M $4.22M +$18.8M Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-13
Q4 2022 $4.31M -$27.9M -$7.57M -37.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $11.9M -$4.88M +$20.4M +80.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 -$8.47M $51.6M +$71.6M Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-26
Q1 2022 -$80M -$14.5M +$7.9M +35.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-10-26
Q4 2021 -$87.9M -$20.3M -$1.42M -7.52% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$86.5M -$25.2M -$9.21M -57.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$77.3M -$19.9M -$2.68M -15.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$74.6M -$22.4M -$18.4M -454% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$56.2M -$18.9M -$5.3M -38.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$50.9M -$16M -$3.33M -26.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$47.6M -$17.2M -$3.47M -25.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-12
Q1 2020 -$44.1M -$4.05M +$11M +73.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-12
Q4 2019 -$55.2M -$13.6M -$2.77M -25.6% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-04
Q3 2019 -$52.4M -$12.7M -$5.01M -65.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$47.4M -$13.8M -$7.3M -113% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-05
Q1 2019 -$40.1M -$15.1M -$10M -199% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-05
Q4 2018 -$30.1M -$10.8M -$5.08M -88.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-20
Q3 2018 -$25M -$7.69M -$1.9M -32.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$23.1M -$6.48M -$605K -10.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-07
Q1 2018 -$22.5M -$5.04M -$904K -21.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-07
Q4 2017 -$21.6M -$5.75M -$2M -53.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-08
Q3 2017 -$19.6M -$5.79M -$1.02M -21.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$18.5M -$5.88M -$1.04M -21.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 -$17.5M -$4.14M -$546K -15.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 -$16.9M -$3.75M +$1.38M +26.9% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-19
Q3 2016 -$18.3M -$4.77M +$280K +5.54% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-02
Q2 2016 -$18.6M -$4.83M -$3.11M -180% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-03
Q1 2016 -$15.5M -$3.59M -$734K -25.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$14.8M -$5.13M -$3.83M -294% Oct 1, 2015 Dec 31, 2015 10-K 2016-03-09
Q3 2015 -$10.9M -$5.05M -$3.55M -236% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 -$7.39M -$1.72M +$351K +16.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 -$7.74M -$2.86M -$1.12M -64.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$6.61M -$1.3M +$12.1M +90.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 -$18.7M -$1.5M +$11.4M +88.4% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 -$30.1M -$2.08M +$10.3M +83.2% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 -$40.4M -$1.73M +$6.33M +78.5% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 -$46.7M -$13.4M +$2.5M +15.8% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$49.2M -$12.9M -$5.02M -63.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$44.2M -$12.4M -$26.9M -185% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$17.3M -$8.07M -$10.3M -457% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$7M -$15.9M -$6.07M -61.9% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-14
Q3 2012 -$933K -$7.88M +$1.18M +13% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-14
Q2 2012 -$2.11M $14.5M +$16.7M Apr 1, 2012 Jun 30, 2012 10-K 2014-03-14
Q1 2012 -$18.9M $2.26M -$10.3M -82.1% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-14
Q4 2011 -$8.53M -$9.81M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$9.05M -$11.5M -464% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 -$2.26M -$6.04M -160% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 $12.6M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 $2.49M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 $3.78M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.